Shandong Sito Bio-Technology300583.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Shandong Sito Bio-Technology (300583.SZ) trades at a P/E of 254.00x, P/B of 1.41x, P/S of 2.02x, and a dividend yield of 0.11%.
Longitudinal percentile comparison: P/E sits at the 98th percentile over the trailing 10Y window (vs. 85th percentile over 3Y); P/B sits at the 16th percentile over the trailing 10Y window (vs. 27th percentile over 3Y); P/S sits at the 12th percentile over the trailing 10Y window (vs. 18th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 94th percentile within its industry and the 93rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.11%, ranking at the 46th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 81.4 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Shandong Sito Bio-Technology operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300583 · SZSE: 300583 · 300583
Want the full picture on whether Shandong Sito Bio-Technology (300583.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 254.00 | ||||||
| P/B (MRQ) | 1.41 | ||||||
| P/S (TTM) | 2.02 | ||||||
| Dividend Yield | 0.11% | ||||||
| Buyback + Div Yield | 0.11% |